Related references
Note: Only part of the references are listed.Seroprevalence and associated risk factors of Toxoplasma gondii and Neospora caninum infections in cattle in Central India
Bhavana K. Hebbar et al.
PARASITOLOGY INTERNATIONAL (2022)
A recombinant protein vaccine encoding Toxoplasma gondii Cyst wall 2 (dense granule protein 47) provides partial protection against acute and chronic T. gondii infection in BALB/c mice
Xiaowei Tian et al.
ACTA TROPICA (2022)
Comparison of real-time PCR and nested PCR for toxoplasmosis diagnosis in toxoplasmic retinochoroiditis patients
Khadijeh Khanaliha et al.
BMC INFECTIOUS DISEASES (2021)
Seroprevalence and risk factors of Toxoplasma gondii infection among veterinary personnel and abattoir workers in Central India
Abhijit S. Deshmukh et al.
PARASITOLOGY INTERNATIONAL (2021)
Toxoplasma gondii induces robust humoral immune response against cyst wall antigens in chronically infected animals and humans
Abhijit S. Deshmukh et al.
MICROBIAL PATHOGENESIS (2021)
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Saghi Nooraei et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Mucosal Administration of Recombinant Baculovirus Displaying Toxoplasma gondii ROP4 Confers Protection Against T. gondii Challenge Infection in Mice
Keon-Woong Yoon et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Immunization With a DNA Vaccine Encoding the Toxoplasma gondii' s GRA39 Prolongs Survival and Reduce Brain Cyst Formation in a Murine Model
Yuchao Zhu et al.
FRONTIERS IN MICROBIOLOGY (2021)
Succinylated Wheat Germ Agglutinin Colocalizes with the Toxoplasma gondii Cyst Wall Glycoprotein CST1
Rebekah B. Guevara et al.
MSPHERE (2020)
Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice
Dong-Hun Lee et al.
KOREAN JOURNAL OF PARASITOLOGY (2019)
A systematic review on the role of GRA proteins of Toxoplasma gondii in host immunization
Fatemeh Rezaei et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2019)
Observations on bradyzoite biology
Vincent Tu et al.
MICROBES AND INFECTION (2018)
Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity
Marijo S. Roiko et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2018)
Chronic Toxoplasma infection is associated with distinct alterations in the synaptic protein composition
Daniel Lang et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Virus-like particle vaccines expressing Toxoplasma gondii rhoptry protein 18 and microneme protein 8 provide enhanced protection
Su-Hwa Lee et al.
VACCINE (2018)
Drug Resistance in Toxoplasma gondii
Mahbobeh Montazeri et al.
FRONTIERS IN MICROBIOLOGY (2018)
Brains and Brawn: Toxoplasma Infections of the Central Nervous System and Skeletal Muscle
Elizabeth A. Wohlfert et al.
TRENDS IN PARASITOLOGY (2017)
Making Home Sweet and Sturdy: Toxoplasma gondii ppGalNAc-Ts Glycosylate in Hierarchical Order and Confer Cyst Wall Rigidity
Tadakimi Tomita et al.
MBIO (2017)
The known and missing links between Toxoplasma gondii and schizophrenia
Hany M. Elsheikha et al.
METABOLIC BRAIN DISEASE (2016)
CD73-Generated Adenosine Is Critical for Immune Regulation during Toxoplasma gondii Infection
Deeqa A. Mahamed et al.
INFECTION AND IMMUNITY (2015)
Vaccination with Recombinant Microneme Proteins Confers Protection against Experimental Toxoplasmosis in Mice
Camila Figueiredo Pinzan et al.
PLOS ONE (2015)
Buccal and sublingual vaccine delivery
Heleen Kraan et al.
JOURNAL OF CONTROLLED RELEASE (2014)
The Toxoplasma gondii Cyst Wall Protein CST1 Is Critical for Cyst Wall Integrity and Promotes Bradyzoite Persistence
Tadakimi Tomita et al.
PLOS PATHOGENS (2013)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Natasha Kushnir et al.
VACCINE (2012)
Vaccines against Toxoplasma gondii Status, challenges and future directions
Qi Liu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
A Critical Role for SOCS3 in Innate Resistance to Toxoplasma gondii
Ryan J. Whitmarsh et al.
CELL HOST & MICROBE (2011)
Cutting Edge: Limited Specialization of Dendritic Cell Subsets for MHC Class II-Associated Presentation of Viral Particles
Susanne A. Keller et al.
JOURNAL OF IMMUNOLOGY (2010)
Vaccination concepts against Toxoplasma gondii
Joao Luis Garcia
EXPERT REVIEW OF VACCINES (2009)
Kinetics of Immune Responses to Influenza Virus-Like Particles and Dose-Dependence of Protection with a Single Vaccination
Fu Shi Quan et al.
JOURNAL OF VIROLOGY (2009)
Use of MAG1 recombinant antigen for diagnosis of Toxoplasma gondii infection in humans
Lucyna Holec et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus
Fu-Shi Quan et al.
JOURNAL OF VIROLOGY (2007)
Mucosal immunity and vaccines
J Holmgren et al.
NATURE MEDICINE (2005)
Veterinary parasitic vaccines: pitfalls and future directions
J Vercruysse et al.
TRENDS IN PARASITOLOGY (2004)
Initial characterization of CST1, a Toxoplasma gondii cyst wall glycoprotein
YW Zhang et al.
INFECTION AND IMMUNITY (2001)
Influenza virus matrix protein is the major driving force in virus budding
P Gómez-Puertas et al.
JOURNAL OF VIROLOGY (2000)
B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii
PC Sayles et al.
INFECTION AND IMMUNITY (2000)
Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase
H Kang et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
